A Bivalent Protease-Activated Receptor-Derived Peptide Mimics Neuronal Anti-Apoptotic Activity of Activated Protein C
Open Access
- 22 August 2025
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 12 (9) , 899
Abstract
Activated protein C (APC) exerts anticoagulant and cytoprotective cell signaling activities. APC’s cell signaling requires protease-activated receptor (PAR) PAR1 and PAR3, and APC’s PAR cleavages generate peptides capable of agonizing biased G-protein coupled receptor (GPCR) cytoprotective signaling, resulting in anti-inflammatory and anti-apoptotic activities and endothelial barrier stabilization. The PAR-sequence-derived 34-residue “G10 peptide” comprising PAR1 residues 47–55 covalently attached by a 10-glycine linker to PAR3 residues 51–65 is an orthosteric/allosteric bivalent GPCR agonist that potently mimics APC’s anti-inflammatory activity and endothelial barrier stabilization activity. The objective of this study was to determine whether the G10 peptide mimics APC’s anti-apoptotic activity using cultured murine neurons challenged by N-methyl-d-aspartate that provokes neuronal apoptosis. In these new studies, the G10 peptide mimicked APC’s anti-apoptotic activity. Thus, the PAR-derived 34-residue G10 peptide mimics APC’s three major cytoprotective activities, namely anti-inflammatory and anti-apoptotic activities and endothelial barrier stabilization. Peptides that agonize GPCRs provide promising and currently approved drugs; e.g., semaglutide and tirzepatide that contain 31 and 39 amino acid residues, respectively. Thus, this new study adds to the rationale for pursuing further studies of the G10 peptide for potential therapeutic value for multiple pathologies where APC or signaling-selective APC variants are therapeutic in preclinical animal studies.Keywords
Funding Information
- National Institutes of Health (R01NS117827, R01HL142975)
This publication has 30 references indexed in Scilit:
- GLP-1-based therapies for diabetes, obesity and beyondNature Reviews Drug Discovery, 2025
- GPCR drug discovery: new agents, targets and indicationsNature Reviews Drug Discovery, 2025
- Engineered Cyclotide Blocks Neuronal ExcitotoxicityJournal of Medicinal Chemistry, 2024
- An orthosteric/allosteric bivalent peptide agonist comprising covalently linked protease-activated receptor-derived peptides mimics in vitro and in vivo activities of activated protein CJournal of Thrombosis and Haemostasis, 2024
- Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injuryNeuron, 2022
- Advances in therapeutic peptides targeting G protein-coupled receptorsNature Reviews Drug Discovery, 2020
- Neuroprotective effects of vitexin by inhibition of NMDA receptors in primary cultures of mouse cerebral cortical neuronsMolecular and Cellular Biochemistry, 2013
- Influence of the NR3A subunit on NMDA receptor functionsProgress in Neurobiology, 2010
- Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial CellsJournal of Biological Chemistry, 2006
- Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures.Proceedings of the National Academy of Sciences, 1995